Bharat Biotech slashes price of malaria vaccine MOSQIVAC by 40%
SENSEX 73,123.83 -125.56 NIFTY 22,600.00 -87.65 CRUDEOIL 9,610.00 + 126.00 GOLD 142,661.00 -648.00 SILVER 195,420.00 -4,179.00 SENSEX 73,123.83 -125.56 NIFTY 22,600.00 -87.65 NIFTY 22,600.00 -87.65 CRUDEOIL 9,610.00 +…

-125.56
NIFTY 22,600.00-87.65
CRUDEOIL 9,610.00+ 126.00
GOLD 142,661.00-648.00
SILVER 195,420.00-4,179.00
SENSEX 73,123.83-125.56
NIFTY 22,600.00-87.65
NIFTY 22,600.00-87.65
CRUDEOIL 9,610.00+ 126.00
CRUDEOIL 9,610.00+ 126.00
GOLD 142,661.00-648.00
'; } document.getElementById("lgdv").innerHTML = htmlElements; } function numberformat(i) { return Number(parseFloat(i).toFixed(2)).toLocaleString('en', { minimumFractionDigits: 2 }) } async function gatherResponse(response) { const { headers } = response; const contentType = headers.get('content-type') || ''; if (contentType.includes('application/json')) { return await response.json() } return response.text(); } function getWidth() { if (Math.max(document.body.scrollWidth,document.documentElement.scrollWidth,document.body.offsetWidth,document.documentElement.offsetWidth,document.documentElement.clientWidth) > 991) { document.getElementById("mob").style.display = "none"; document.getElementById("lgdv").style.display = "block"; } else { document.getElementById("mob").style.display = "block"; document.getElementById("lgdv").style.display = "none"; } } getWidth(); THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.Bharat Biotech said the move will help protect another 1 million children and generate $50 million in savings.
By PTI
Updated - October 23, 2026 at 04:22 PM. | New DelhiBharat Biotech on Friday announced a nearly 40 per cent reduction in the price of MOSQIVAC, the RTS,S/AS01 malaria vaccine.
In a post on social media platform X, Bharat Biotech said the move will help protect another 1 million children and generate USD 50 million in savings.
"Under an agreement executed by UNICEF and financially backed by Gavi, the vaccine price will be reduced by approximately 40 per cent," the Hyderabad-based biotech company said in the post.
"Developed by GSK, RTS, S/AS01 is the world's first malaria vaccine and is now manufactured by Bharat Biotech under the brand name MOSQIVAC®," it said.
The need is urgent as one child dies from malaria every minute, the company added.
Published on October 23, 2026
THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.Sign into Unlock benefits!- Access 10 free stories per month
- Get notified by email for early preview to new features, discounts & offers
Figures reflect the source report and its stated period. This article is for information and is not investment advice.



